The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
AXOGEN INC | COM | 05463X106 | 35,652 | 1,759,699 | SH | SOLE | 1,759,699 | 0 | 0 | ||
BIOVENTUS | COM CL A | 09075A108 | 184,838 | 12,096,702 | SH | SOLE | 12,096,702 | 0 | 0 | ||
CATALYST BIOSCIENCES INC | COM NEW | 14888D208 | 396 | 78,622 | SH | SOLE | 78,622 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 42,580 | 4,190,921 | SH | SOLE | 4,190,921 | 0 | 0 | ||
MEDICINOVA INC | COM NEW | 58468P206 | 5,585 | 1,105,941 | SH | SOLE | 1,105,941 | 0 | 0 | ||
MIMEDX GROUP, INC. | COM | 602496101 | 240,779 | 23,376,623 | SH | SOLE | 23,376,623 | 0 | 0 | ||
REVANCE THERAPEUTICS INC | COM | 761330109 | 77,141 | 2,759,950 | SH | SOLE | 2,759,950 | 0 | 0 | ||
TELA BIO, INC. | COM | 872381108 | 23,543 | 1,580,089 | SH | SOLE | 1,580,089 | 0 | 0 | ||
VENUS CONCEPT, INC. | COM | 92332W105 | 29,182 | 12,417,856 | SH | SOLE | 12,417,856 | 0 | 0 |